Literature DB >> 31153390

Neo-adjuvant chemoradiotherapy response prediction using MRI based ensemble learning method in rectal cancer patients.

Sajad P Shayesteh1, Afsaneh Alikhassi2, Armaghan Fard Esfahani3, M Miraie4, Parham Geramifar3, Ahmad Bitarafan-Rajabi5, Peiman Haddad6.   

Abstract

OBJECTIVES: The aim of this study was to investigate and validate the performance of individual and ensemble machine learning models (EMLMs) based on magnetic resonance imaging (MRI) to predict neo-adjuvant chemoradiation therapy (nCRT) response in rectal cancer patients. We also aimed to study the effect of Laplacian of Gaussian (LOG) filter on EMLMs predictive performance.
METHODS: 98 rectal cancer patients were divided into a training (n = 53) and a validation set (n = 45). All patients underwent MRI a week before nCRT. Several features from intensity, shape and texture feature sets were extracted from MR images. SVM, Bayesian network, neural network and KNN classifiers were used individually and together for response prediction. Predictive performance was evaluated using the area under the receiver operator characteristic (ROC) curve (AUC).
RESULTS: Patients' nCRT responses included 17 patients with Grade 0, 28 with Grade 1, 34 with Grade 2, and 19 with Grade 3 according to AJCC/CAP pathologic grading. In without preprocessing MR Image the best result was for Bayesian network classifier with AUC and accuracy of 75.2% and 80.9% respectively, which was confirmed in the validation set with an AUC and accuracy of 74% and 79% respectively. In EMLMs the best result was for 4 (SVM.NN.BN.KNN) classifier EMLM with AUC and accuracy of 97.8% and 92.8% in testing and 95% and 90% in validation set respectively.
CONCLUSIONS: In conclusion, we observed that machine learning methods can used to predict nCRT response in patients with rectal cancer. Preprocessing LOG filters and EL models can improve the prediction process.
Copyright © 2019 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemoradiotherapy; MRI; Machine learning; Radiomics; Rectal cancer

Mesh:

Year:  2019        PMID: 31153390     DOI: 10.1016/j.ejmp.2019.03.013

Source DB:  PubMed          Journal:  Phys Med        ISSN: 1120-1797            Impact factor:   2.685


  10 in total

1.  Studying local tumour heterogeneity on MRI and FDG-PET/CT to predict response to neoadjuvant chemoradiotherapy in rectal cancer.

Authors:  Niels W Schurink; Simon R van Kranen; Maaike Berbee; Wouter van Elmpt; Frans C H Bakers; Sander Roberti; Joost J M van Griethuysen; Lisa A Min; Max J Lahaye; Monique Maas; Geerard L Beets; Regina G H Beets-Tan; Doenja M J Lambregts
Journal:  Eur Radiol       Date:  2021-02-10       Impact factor: 5.315

2.  PET/MRI Radiomics in Rectal Cancer: a Pilot Study on the Correlation Between PET- and MRI-Derived Image Features with a Clinical Interpretation.

Authors:  Barbara Juarez Amorim; Angel Torrado-Carvajal; Shadi A Esfahani; Sara S Marcos; Mark Vangel; Dan Stein; David Groshar; Onofrio A Catalano
Journal:  Mol Imaging Biol       Date:  2020-10       Impact factor: 3.488

Review 3.  Radiomics with artificial intelligence: a practical guide for beginners.

Authors:  Burak Koçak; Emine Şebnem Durmaz; Ece Ateş; Özgür Kılıçkesmez
Journal:  Diagn Interv Radiol       Date:  2019-11       Impact factor: 2.630

Review 4.  Rectal MRI radiomics for predicting pathological complete response: Where we are.

Authors:  Joao Miranda; Gary Xia Vern Tan; Maria Clara Fernandes; Onur Yildirim; John A Sims; Jose de Arimateia Batista Araujo-Filho; Felipe Augusto de M Machado; Antonildes N Assuncao-Jr; Cesar Higa Nomura; Natally Horvat
Journal:  Clin Imaging       Date:  2021-11-16       Impact factor: 2.420

Review 5.  Advanced analytics and artificial intelligence in gastrointestinal cancer: a systematic review of radiomics predicting response to treatment.

Authors:  Nina J Wesdorp; Tessa Hellingman; Elise P Jansma; Jan-Hein T M van Waesberghe; Ronald Boellaard; Cornelis J A Punt; Joost Huiskens; Geert Kazemier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-12-16       Impact factor: 9.236

6.  Incorporating radiomics into clinical trials: expert consensus endorsed by the European Society of Radiology on considerations for data-driven compared to biologically driven quantitative biomarkers.

Authors:  Laure Fournier; Lena Costaridou; Luc Bidaut; Nicolas Michoux; Frederic E Lecouvet; Lioe-Fee de Geus-Oei; Ronald Boellaard; Daniela E Oprea-Lager; Nancy A Obuchowski; Anna Caroli; Wolfgang G Kunz; Edwin H Oei; James P B O'Connor; Marius E Mayerhoefer; Manuela Franca; Angel Alberich-Bayarri; Christophe M Deroose; Christian Loewe; Rashindra Manniesing; Caroline Caramella; Egesta Lopci; Nathalie Lassau; Anders Persson; Rik Achten; Karen Rosendahl; Olivier Clement; Elmar Kotter; Xavier Golay; Marion Smits; Marc Dewey; Daniel C Sullivan; Aad van der Lugt; Nandita M deSouza
Journal:  Eur Radiol       Date:  2021-01-25       Impact factor: 5.315

7.  18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy.

Authors:  Giulia Capelli; Cristina Campi; Quoc Riccardo Bao; Francesco Morra; Carmelo Lacognata; Pietro Zucchetta; Diego Cecchin; Salvatore Pucciarelli; Gaya Spolverato; Filippo Crimì
Journal:  Nucl Med Commun       Date:  2022-04-26       Impact factor: 1.698

8.  Mapping of clinical research on artificial intelligence in the treatment of cancer and the challenges and opportunities underpinning its integration in the European Union health sector.

Authors:  Elena-Ramona Popescu; Marius Geantă; Angela Brand
Journal:  Eur J Public Health       Date:  2022-06-01       Impact factor: 4.424

Review 9.  Big Data to Knowledge: Application of Machine Learning to Predictive Modeling of Therapeutic Response in Cancer.

Authors:  Sukanya Panja; Sarra Rahem; Cassandra J Chu; Antonina Mitrofanova
Journal:  Curr Genomics       Date:  2021-12-16       Impact factor: 2.689

Review 10.  Applications of Artificial Intelligence in Screening, Diagnosis, Treatment, and Prognosis of Colorectal Cancer.

Authors:  Hang Qiu; Shuhan Ding; Jianbo Liu; Liya Wang; Xiaodong Wang
Journal:  Curr Oncol       Date:  2022-03-07       Impact factor: 3.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.